These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16028156)

  • 1. Pneumococcal serotypes in the elderly.
    Kellner JD; Mandell L
    Clin Infect Dis; 2005 Aug; 41(4):488-9. PubMed ID: 16028156
    [No Abstract]   [Full Text] [Related]  

  • 2. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.
    Feikin DR; Klugman KP
    Clin Infect Dis; 2002 Sep; 35(5):547-55. PubMed ID: 12173128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 4. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?
    Moore MR; Whitney CG
    Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
    Gonzalez BE; Hulten KG; Lamberth L; Kaplan SL; Mason EO;
    Pediatr Infect Dis J; 2006 Apr; 25(4):301-5. PubMed ID: 16567980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pneumococcal disease in children: changing serotypes and clinical expression of disease.
    Calbo E; Garau J
    Clin Infect Dis; 2005 Dec; 41(12):1821-2; author reply 1822-3. PubMed ID: 16288412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG
    J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
    Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the link between pneumococcal serotypes and invasive disease.
    Soley C; Arguedas A
    Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conjugate vaccine and invasive pneumococcal disease.
    Konradsen HB; Nokleby H
    N Engl J Med; 2003 Aug; 349(7):714-6; author reply 714-6. PubMed ID: 12921091
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971-2004) and serotype coverage by marketed pneumococcal vaccines.
    Akduman D; Ehret JM; Judson FN
    Clin Microbiol Infect; 2006 Nov; 12(11):1141-3. PubMed ID: 17002617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?
    Debbache K; Varon E; Hicheri Y; Legrand P; Donay JL; Ribaud P; Cordonnier C
    Clin Microbiol Infect; 2009 Sep; 15(9):865-8. PubMed ID: 19549222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R
    Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(41):1077-80. PubMed ID: 17947966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report.
    Wkly Epidemiol Rec; 2010 Oct; 85(43):434-6. PubMed ID: 21038716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.